Bio-Rad Laboratories, Inc. (BIO) News
Filter BIO News Items
BIO News Results
|Loading, please wait...|
BIO News Highlights
- For BIO, its 30 day story count is now at 27.
- Over the past 15 days, the trend for BIO's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
- RAD, AMN and BAX are the most mentioned tickers in articles about BIO.
Latest BIO News From Around the Web
Below are the latest news stories about Bio-Rad Laboratories Inc that investors may wish to consider to help them evaluate BIO as an investment opportunity.
HERCULES, Calif., February 25, 2022--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, is hosting an in-person investor day beginning at 10:30 a.m. EST today in New York City. During the event, members of Bio-Rad’s executive leadership team will provide an in-depth overview of the Company’s growth strategy and new long-term financial targets, as well a closer look at the drivers within the two core business segments – Life
Strength in Myriad Genetics' (MYGN) Molecular Diagnostic segment has drove Q4 sales despite a challenging business environment.
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Integra (IART) records strong recovery in order demand in Q4 on broad-based strength in Neurosurgery and sales from the company's new CereLink ICP monitoring.
Insulet's (PODD) fourth-quarter 2021 revenues improved year over year on a strong performance of Omnipod, both in U.S. and international markets.
Continued strong international performance and introduction of products drove NuVasive's (NUVA) revenues in the fourth quarter of 2021.
Cerner's (CERN) fourth-quarter results benefit from gains across four of its business units.
Despite the weak bottom-line performance, LHC Group's (LHCG) fourth-quarter results benefit from organic growth in home health admissions.
Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.